id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-E-2349-0006,FDA,FDA-2014-E-2349,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2016-11-16T05:00:00Z,2016,11,2016-11-16T05:00:00Z,,2016-11-16T17:53:52Z,,0,0,0900006482399eec
FDA-2014-E-2349-0005,FDA,FDA-2014-E-2349,Determination of Regulatory Review Period for Purposes of Patent  Extension; OPSUMIT,Notice,Determinations,2016-03-10T05:00:00Z,2016,3,2016-03-10T05:00:00Z,2016-09-07T03:59:59Z,2016-03-10T15:02:46Z,2016-05389,0,0,0900006481eb7a77